The comparison to the New York mob boss was only the beginning of Citron Research's inflammatory comments
The biotech saw shares fall 2.3% after reporting in-line earnings and worse-than-expected revenue.
The company is rumored to be up for sale.
McKesson, Bristol-Myers and Varian were having a busy morning.
Johnson & Johnson will purchase Swiss biotech Actelion Pharmaceuticals for $30 billion, and it plans to spin out the company's research and development unit into a separate business.
Abbott Labs' shares fell nearly 1% in premarket trading after the company reported mixed earnings results.
CEO Alex Gorsky dishes on Monday's meeting with President Trump during Johnson & Johnson's conference call.
It's unclear how much of the hefty $4,500 price pharmacy benefit managers or insurers will agree to pay to keep Auvi-Q free for most patients.
Other movers included Mannkind, Perrigo and Bristol-Myers Squibb.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.